---
title: "GRAY MICHAEL — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ad02e87b-81eb-5bb2-857a-ab43fee6a42e
json: https://whiteintel.dev/api/public/dossier/ad02e87b-81eb-5bb2-857a-ab43fee6a42e
identifier: sec:0001271411
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GRAY MICHAEL

**Type:** Person  
**Jurisdiction:** US  
**Identifier:** `sec:0001271411`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ad02e87b-81eb-5bb2-857a-ab43fee6a42e  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ad02e87b-81eb-5bb2-857a-ab43fee6a42e  

## Ownership & control

### Holdings / subsidiaries

- **Upstream Bio, Inc.** (officer) — https://whiteintel.dev/entity/d4a67260-0136-5e37-912a-3a65173d819d
- **Upstream Bio, Inc.** (officer) — https://whiteintel.dev/entity/d4a67260-0136-5e37-912a-3a65173d819d
- **Enliven Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/a92f7bfe-f722-5087-8729-de9a9c48f28d
- **POINT BIOPHARMA GLOBAL INC.** (director) — https://whiteintel.dev/entity/43e8e7b1-fb25-50ef-88ea-ea634f8c1919
- **X4 Pharmaceuticals, Inc** (officer) — https://whiteintel.dev/entity/faa4b0df-34a4-5462-b727-ec322e28bc73
- **X4 Pharmaceuticals, Inc** (director) — https://whiteintel.dev/entity/faa4b0df-34a4-5462-b727-ec322e28bc73
- **CURIS INC** (officer) — https://whiteintel.dev/entity/1a33a73a-f742-5c84-a280-d005afd86251

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GRAY MICHAEL**. Human view: https://whiteintel.dev/entity/ad02e87b-81eb-5bb2-857a-ab43fee6a42e · Structured JSON: https://whiteintel.dev/api/public/dossier/ad02e87b-81eb-5bb2-857a-ab43fee6a42e._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._